Home / Research and experimental development on biotechnology (except medical and veterinary science)

SYMRAY BIOPHARMA PTE. LTD.

Live CompanyUEN 202546700ZLocal Company

SYMRAY BIOPHARMA PTE. LTD. is a local company in Singapore with UEN 202546700Z. It was registered on 21 Oct 2025. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202546700Z
StatusLive Company
Entity typeLocal Company, Private Company Limited by Shares
Registered21 Oct 2025
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity72106 Research and experimental development on medical and veterinary sciences
Address60 PAYA LEBAR ROAD, #11-53, PAYA LEBAR SQUARE, Singapore 409051
21342 companies at this address
AreaGeylang · District 14 (Geylang, Eunos)
Nearest stationPaya Lebar MRT, about 66 m
Officers5

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.